Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)

Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL) / Ferreri, Aj; Dell'Oro, S; Foppoli, M; Brandes, Aa; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Reni, M. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 23:16(2005), pp. 121S-121S.